Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

Ann Surg Oncol. 2023 Mar;30(3):1305-1308. doi: 10.1245/s10434-022-12916-z. Epub 2022 Dec 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Neoplasms* / surgery
  • Patients
  • SARS-CoV-2
  • Vaccination / adverse effects